Naglazyme
Generic name: Galsulfase
Drug class:
Lysosomal enzymes
Usage of Naglazyme
Naglazyme contains an enzyme that occurs naturally in the body in healthy people. Some people lack this enzyme because of a genetic disorder. Galsulfase helps replace this missing enzyme in such people.
Naglazyme is used to treat some of the symptoms of a genetic condition called mucopolysaccharidosis VI (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis type 6), or MPS VI, also called Maroteaux-Lamy syndrome.
MPS VI is a metabolic disorder in which the body lacks the enzyme needed to break down certain natural substances. These substances can build up in the body, causing enlarged organs, abnormal bone structure, changes in facial features, breathing problems, heart problems, vision or hearing loss, and changes in mental or physical abilities.
Naglazyme may improve walking and stair-climbing ability in people with this condition. However, this medication is not a cure for MPS VI.
Naglazyme side effects
Get emergency medical help if you have signs of an allergic Reaction to Naglazyme: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
An allergic reaction may occur during or shortly after infusion of this medicine (up to 24 hours later). Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as:
Even though it may not be a side effect of galsulfase, increased pressure on the spinal cord is a complication of MPS VI that may occur while you are using Naglazyme. Tell your doctor right away if you have any symptoms of spinal cord compression: back pain, loss of movement in any part of your body, loss of bowel or bladder control.
Call your doctor at once if you have:
Common Naglazyme side effects may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Naglazyme
Your Naglazyme infusion may be delayed if you have a fever or cold symptoms.
To make sure Naglazyme is safe for you, tell your doctor if you have ever HAD:
Tell your doctor if you are pregnant or breastfeeding.
Your name may need to be listed on an MPS IV Registry while you are using Naglazyme. The purpose of this registry is to track the progression of this disorder and the effects that galsulfase has on long-term treatment of MPS IV. The registry also tracks the effects of galsulfase on a baby if you are pregnant or breastfeeding.
Relate drugs
- Agalsidase beta
- Aldurazyme
- Alglucerase
- Alglucosidase alfa
- Avalglucosidase alfa
- Avalglucosidase alfa-ngpt
- Myozyme
- Brineura
- Ceredase
- Cerezyme
- Cerliponase alfa
- Elaprase
- Elelyso
- Elfabrio
- Elosulfase alfa
- Fabrazyme
- Galsulfase
- Idursulfase
- Imiglucerase
- Kanuma
- Lamzede
- Laronidase
- Lumizyme
- Mepsevii
- Naglazyme
- Nexviazyme
- Olipudase alfa
- Olipudase alfa-rpcp
- Pegunigalsidase alfa-iwxj
- Pombiliti
- Sebelipase alfa
- Taliglucerase alfa
- Velaglucerase alfa
- Velmanase alfa-tycv
- Vestronidase alfa
- Vestronidase alfa-vjbk
- Vimizim
- VPRIV
- Xenpozyme
How to use Naglazyme
Usual Adult Dose for Mucopolysaccharidosis Type VI:
1 mg/kg IV once a week Comments: -Clinical studies did not include patients older than 29 years and it is therefore unknown if they respond differently than younger patients. Use: For the treatment of patients with Mucopolysaccharidosis VI (MPS VI [Maroteaux-Lamy syndrome])
Usual Pediatric Dose for Mucopolysaccharidosis Type VI:
5 years or older: 1 mg/kg IV once a week Use: For the treatment of patients with MPS VI (Maroteaux-Lamy syndrome)
Warnings
An allergic reaction may occur during or shortly after the Naglazyme infusion. Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as chest pain, trouble breathing, vomiting, skin rash or redness, and feeling like you might pass out.
What other drugs will affect Naglazyme
Other drugs may interact with galsulfase, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions